Sivik Global Healthcare’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-51,868
Closed -$2.39M 53
2023
Q4
$2.39M Buy
+51,868
New +$2.21M 1% 36
2021
Q3
Sell
-42,437
Closed -$2.18M 51
2021
Q2
$2.18M Buy
+42,437
New +$2.19M 0.43% 44
2019
Q2
Sell
-75,444
Closed -$3.25M 68
2019
Q1
$3.25M Sell
75,444
-29,047
-28% -$1.17M 1.2% 40
2018
Q4
$3.82M Buy
104,491
+24,331
+30% +$904K 2.06% 23
2018
Q3
$3.22M Sell
80,160
-28,291
-26% -$1.13M 1.15% 40
2018
Q2
$4.16M Buy
108,451
+37,722
+53% +$1.39M 1.6% 31
2018
Q1
$2.42M Buy
+70,729
New +$2.48M 1.13% 37
2017
Q4
Sell
-56,583
Closed -$1.89M 79
2017
Q3
$1.89M Buy
+56,583
New +$1.95M 0.64% 57

Other funds holding QGEN

Sivik Global Healthcare's QGEN Position: Q1 2024 in Review

Sivik Global Healthcare sold out of Qiagen (QGEN) in Q1 2024, closing a stake of 51,868 shares — an estimated $2.39M sold.

Sivik Global Healthcare first reported a position in QGEN in Q3 2017 and held it in 8 quarters. The position peaked at $4.16M in Q2 2018. 282 funds tracked by Wall St. Rank hold QGEN as of Q1 2024.

  • Sivik Global Healthcare reported no remaining Qiagen position as of Q1 2024 after selling out during the quarter.
  • Sivik Global Healthcare sold 51,868 Qiagen shares in Q1 2024, an estimated $2.39M.
  • Sivik Global Healthcare first reported a position in Qiagen in Q3 2017 and held it in 8 quarters.
  • Sivik Global Healthcare's Qiagen position peaked at $4.16M in Q2 2018.
  • 282 funds tracked by Wall St. Rank held Qiagen as of Q1 2024.

Based on Sivik Global Healthcare's 13F filing for Q1 2024, filed 1 May 2024.